The FDA’s approval of controversial Alzheimer’s drugs has led to the resignation of many employees of the agency. Now, a new law passed by congress will allow computer models in place of animal trials for FDA approval.

#Repatha #Aduhelm #AnimalTesting #FDAModernizationAct